Leptin mediates protection of hydrogen sulfide against 6-hydroxydopamine-induced Parkinson's disease: Involving enhancement in Warburg effect

Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed

Wang, R. (2012) · Physiological Reviews · doi:10.1152/physrev.00017.2011 · Cited by 1,939 · see citing works

The Role of Oxidative Stress in Parkinson's Disease

Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845 · see citing works

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · see citing works

Cancer's Molecular Sweet Tooth and the Warburg Effect

Kim, J., & Dang, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1501 · Cited by 1,217 · see citing works

From Lesions to Leptin

Elmquist, J. K., Elias, C. F., & Saper, C. B. (1999) · Neuron · doi:10.1016/s0896-6273(00)81084-3 · Cited by 1,160 · see citing works

Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications

Kelesidis, T., Kelesidis, I., Chou, S. H.-H., & Mantzoros, C. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00008 · Cited by 667 · see citing works

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 652 · see citing works

Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment

Pagonabarraga, J., Kulisevsky, J., Strafella, A. P., & Krack, P. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00019-8 · Cited by 556 · see citing works

LACTIC DEHYDROGENASE IN HUMAN NEOPLASTIC TISSUES.

Goldman, R. D., Kaplan, N. O., & Hall, T. C. (1964) · PubMed · Cited by 355 · see citing works

Glial glycolysis is essential for neuronal survival in Drosophila

Volkenhoff, A., Weiler, A., Letzel, M., Stehling, M., Klämbt, C., & Schirmeier, S. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.006 · Cited by 339 · see citing works

New aspects of the Warburg effect in cancer cell biology

Bensinger, S. J., & Christofk, H. R. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.02.003 · Cited by 309 · see citing works

CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson’s disease

Pabon, M. M., Bachstetter, A. D., Hudson, C. E., Gemma, C., & Bickford, P. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-9 · Cited by 241 · see citing works

Hydrogen Sulfide: A Neuromodulator and Neuroprotectant in the Central Nervous System

Zhang, X., & Bian, J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500185g · Cited by 210 · see citing works

Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection

Ahmed, S. S. S. J., Santosh, W., Kumar, S., & Christlet, H. T. T. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-63 · Cited by 197 · see citing works

Leptin Protects against 6-Hydroxydopamine-induced Dopaminergic Cell Death via Mitogen-activated Protein Kinase Signaling

Weng, Z., Signore, A. P., Gao, Y., Wang, S., Zhang, F., Hastings, T., Yin, X.-M., & Chen, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705426200 · Cited by 163 · see citing works

Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages

Borghammer, P., Chakravarty, M., Jonsdottir, K., Sato, N., Matsuda, H., Ito, K., Arahata, Y., Kato, T., & Gjedde, A. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0246-0 · Cited by 160 · see citing works

Hydrogen Sulfide and Polysulfides as Biological Mediators

Kimura, H. (2014) · Molecules · doi:10.3390/molecules191016146 · Cited by 150 · see citing works

Hydrogen sulfide in pharmacology and medicine – An update

Bełtowski, J. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.01.005 · Cited by 148 · see citing works

Amyloid Beta Resistance in Nerve Cell Lines Is Mediated by the Warburg Effect

Newington, J. T., Pitts, A., Chien, A., Arseneault, R., Schubert, D. A., & Cumming, R. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019191 · Cited by 121 · see citing works

Challenges of modifying disease progression in prediagnostic Parkinson's disease

Salat, D., Noyce, A. J., Schrag, A. E., & TOLOSA, E. S. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00060-0 · Cited by 119 · see citing works

Leptin and the Regulation of the Hypothalamic–Pituitary–Adrenal Axis

Malendowicz, L. K., Ruciński, M., Belloni, A. S., Ziółkowska, A., & Nussdorfer, G. G. (2007) · International review of cytology · doi:10.1016/s0074-7696(07)63002-2 · Cited by 117 · see citing works

Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease

Vlassenko, A. G., Gordon, B. A., Goyal, M. S., Su, Y., Blazey, T. M., Durbin, T. J., Couture, L. E., Christensen, J. J., Jafri, H., Morris, J. C., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.014 · Cited by 107 · see citing works

Evaluation and modification of spectrophotometric procedures for analysis of lactate dehydrogenase, beta-glucuronidase and arylsulphatase in human gingival crevicular fluid collected with filter-paper strips

Lamster, I. B., Hartley, L. J., Oshrain, R. L., & Gordon, J. M. (1985) · Archives of Oral Biology · doi:10.1016/0003-9969(85)90039-1 · Cited by 98 · see citing works

Tumor Acidity as Evolutionary Spite

Alfarouk, K. O., Muddathir, A. K., & Shayoub, M. E. A. (2011) · Cancers · doi:10.3390/cancers3010408 · Cited by 97 · see citing works

Weight loss, body fat mass, and leptin in Parkinson's disease

Lorefält, B., Toss, G., & Granérus, A. (2009) · Movement Disorders · doi:10.1002/mds.22466 · Cited by 91 · see citing works

Hydrogen sulfide inhibits MPP+-induced apoptosis in PC12 cells

Yin, W., He, J., Hu, B., Jiang, Z.-S., & Tang, X. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.05.023 · Cited by 91 · see citing works

Leptin and ghrelin concentrations and weight loss in Parkinson’s disease

Fiszer, U., Michalowska, M., Baranowska, B., Wolińska‐Witort, E., Jeske, W., Jethon, M., Piaścik-Gromada, M., & Marcinowska-Suchowierska, E. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01185.x · Cited by 90 · see citing works

Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept

Yuen, C., Asuthkar, S., Guda, M. R., Tsung, A. J., & Velpula, K. K. (2016) · CNS Oncology · doi:10.2217/cns-2015-0006 · Cited by 82 · see citing works

Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson's disease

Bhattacharjee, N., & Borah, A. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.10.001 · Cited by 81 · see citing works

A New Hope for Neurodegeneration: Possible Role of Hydrogen Sulfide

Gong, Q., Shi, X., Hong, Z., Pan, L., Liu, X.-H., & Zhu, Y. Z. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110128 · Cited by 77 · see citing works

Recent advances in Parkinson’s disease genetics

Lubbe, S. J., & Morris, H. R. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7003-2 · Cited by 77 · see citing works

MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death

Chaudhuri, A., Kabaria, S., Choi, D. C., Mouradian, M. M., & Junn, E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.625962 · Cited by 59 · see citing works

Aerobic glycolysis in amyotrophic lateral sclerosis and Huntington’s disease

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0075 · Cited by 58 · see citing works

Leptin-Induced Endothelium-Dependent Vasorelaxation of Peripheral Arteries in Lean and Obese Rats: Role of Nitric Oxide and Hydrogen Sulfide

Jamróz-Wiśniewska, A., Gertler, A., Solomon, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086744 · Cited by 57 · see citing works

Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models

Hong, C., Chau, K., & Schapira, A. H. V. (2016) · Scientific Reports · doi:10.1038/srep25344 · Cited by 52 · see citing works

Leptin inhibits 1-methyl-4-phenylpyridinium-induced cell death in SH-SY5Y cells

Lu, J., Park, C., Lee, S., Shin, D. W., & Kang, J. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.08.053 · Cited by 51 · see citing works

2‐Deoxyglucose Enhances 1‐Methyl‐4‐Phenyl‐1, 2, 3, 6‐Tetrahydropyridine‐Induced ATP Loss in the Mouse Brain

Chan, P., Langston, J. W., Irwin, I., et al. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb02165.x · Cited by 50 · see citing works

Leptin regulates energy metabolism in MCF-7 breast cancer cells

Blanquer-Rosselló, M. D. M., Oliver, J., Sastre‐Serra, J., Valle, A., & Roca, P. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.01.002 · Cited by 47 · see citing works

Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease

Corona, J. C., Giménez-Cassina, A., Lim, F., & Díaz‐Nido, J. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22357 · Cited by 42 · see citing works

Perfusion and metabolism imaging studies in Parkinson's disease.

Borghammer, P. (2012) · PubMed · Cited by 41 · see citing works

Neuroprotective Effects of Hydrogen Sulfide in Parkinson's Disease Animal Models

Xue, X., & Bian, J. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2014.11.015 · Cited by 36 · see citing works

GRP78 is implicated in the modulation of tumor aerobic glycolysis by promoting autophagic degradation of IKKβ

Li, Z., Wang, Y., Newton, I. P., Zhang, L., Ji, P., & Li, Z. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.030 · Cited by 35 · see citing works

Inhibition of Hydrogen Sulfide Generation Contributes to 1-Methy-4-Phenylpyridinium Ion-Induced Neurotoxicity

Tang, X., Fan, L., Li, Y., et al. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9180-4 · Cited by 35 · see citing works

Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson’s disease: behavioral, histological and biochemical studies

Sarukhani, M. R., Haghdoost-Yazdi, H., Sarbazi-Golezari, A., Babayan-Tazehkand, A., Dargahi, T., & Rastgoo, N. (2018) · Neurological Research · doi:10.1080/01616412.2017.1390903 · Cited by 33 · see citing works

Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders

Lakkappa, N., Krishnamurthy, P. T., Hammock, B. D., Velmurugan, D., & Bharath, M. M. S. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.06.003 · Cited by 30 · see citing works

A 6-Hydroxydopamine In Vivo Model of Parkinson’s Disease

Mercanti, G., Bazzu, G., & Giusti, P. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-536-7_30 · Cited by 26 · see citing works

Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson’s disease

Sarookhani, M. R., Haghdoost-Yazdi, H., Sarbazi-Golezari, A., Babayan-Tazehkand, A., & Rastgoo, N. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000358 · Cited by 23 · see citing works

Hydrogen Sulfide Inhibits Formaldehyde-Induced Senescence in HT-22 Cells via Upregulation of Leptin Signaling

Zhu, W., Ning, M., Peng, Y.-Z., Tang, Y.-Y., Kang, X., Zhan, K., Zou, W., Zhang, P., & Tang, X. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08536-8 · Cited by 22 · see citing works

Exogenous hydrogen sulfide alleviates high glucose-induced cardiotoxicity via inhibition of leptin signaling in H9c2 cells

Zhuang, X., Hu, X., Long, M., et al. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-1997-3 · Cited by 18 · see citing works

Neuropsychiatric manifestations of Parkinson’s disease

Ruiz, R. M. M., Evans, A. H., Velakoulis, D., & Looi, J. C. (2016) · Australasian Psychiatry · doi:10.1177/1039856216654393 · Cited by 13 · see citing works

Untitled work

Elmquist (1998) · doi:10.1002/(sici)1096-9861(19980615)395:4

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

MODIFIED RECOMBINANT HUMAN aFGF PROTECTS TYROSINE HYDROXYLASE NEURONS IN SUBSTANTIA NIGRA OF PARKINSON DISEASE RATS FROM LOSS

Guo, G. (2007)

Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons

Schapira, A. H. V., Cleeter, M. W. J., Muddle, J. R., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20934 · Cited by 90 · see citing works

Repeated administration of MDMA down-regulates preprocholecystokinin mRNA expression but not tyrosine hydroxylase mRNA expression in neurones of the rat substantia nigra

Wotherspoon, G., Savery, D., Priestley, J. V., et al. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90275-5 · Cited by 9 · see citing works

Chronic exposure to aluminum reduces tyrosine hydroxylase expression in the substantia nigra and locomotor performance in rats

Erazi, H., Ahboucha, S., & Gamrani, H. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.053 · Cited by 29 · see citing works

Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication

Lee, M. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i3.148 · Cited by 154 · see citing works